Background: There are many mobile apps for diabetes self-management; however, most target Western populations and lack dietary content relevant to Asian contexts. Our mobile app addresses this gap by providing self-care tools and a database of regionally relevant foods.
Objective: This study aimed to evaluate the effectiveness of the app in improving glycemic control and self-care behaviors among outpatients with uncontrolled type 2 diabetes at our hospital.
Methods: We conducted a randomized controlled trial with adults with type 2 diabetes, hemoglobin A1c (HbA1c) of >7%, and access to a smartphone. Participants were randomized to an intervention group (daily use of the Rama Diabetes Care app) or a control group (standard care), with all receiving diabetes self-management education and support. The app includes 6 features, notably a nutritional logging system with a verified database of Thai and commonly consumed foods, including Asian and Western dishes, as well as blood glucose monitoring, exercise and medication tracking, symptom screening, and weight logging. The primary outcome was HbA1c level, and secondary outcomes included fasting plasma glucose (FPG), low-density lipoprotein cholesterol, estimated glomerular filtration rate, BMI, self-care behaviors, and user satisfaction with the app. The study was conducted between November 29, 2023, and October 30, 2024.
Results: A total of 129 participants were randomized (intervention: n=64, 49.6%; control: n=65, 50.4%). Participants in the intervention group were younger (mean age 54.6, SD 14.3 years vs 61.9, SD 12.0 years; P=.002), whereas baseline HbA1c (mean 9.3%, SD 1.96%) and FPG (mean 179.5, SD 5.9 mg/dL) levels were similar between the groups. Over 6 months, the intervention group showed a greater HbA1c reduction than the control group (mean difference -0.24%), but the difference was not statistically significant (P=.13). Among participants aged <65 years, FPG at 6 months was significantly lower in the intervention group (mean difference -29.3 mg/dL; P=.03). App satisfaction was rated as moderate.
Conclusions: The mobile app achieved glycemic control comparable to that achieved through standard care, with significant improvement in FPG among participants younger than 65 years. Tailor-made apps integrating regionally relevant dietary content may support effective self-management in type 2 diabetes and warrant further evaluation in larger, long-term studies.
{"title":"A Tailor-Made Mobile App With a Local Cuisine Database for Self-Management of Type 2 Diabetes Mellitus: Randomized Controlled Trial.","authors":"Supasuta Wongdama, Wannaporn Paemueang, Chutintorn Sriphrapradang","doi":"10.2196/83685","DOIUrl":"10.2196/83685","url":null,"abstract":"<p><strong>Background: </strong>There are many mobile apps for diabetes self-management; however, most target Western populations and lack dietary content relevant to Asian contexts. Our mobile app addresses this gap by providing self-care tools and a database of regionally relevant foods.</p><p><strong>Objective: </strong>This study aimed to evaluate the effectiveness of the app in improving glycemic control and self-care behaviors among outpatients with uncontrolled type 2 diabetes at our hospital.</p><p><strong>Methods: </strong>We conducted a randomized controlled trial with adults with type 2 diabetes, hemoglobin A1c (HbA1c) of >7%, and access to a smartphone. Participants were randomized to an intervention group (daily use of the Rama Diabetes Care app) or a control group (standard care), with all receiving diabetes self-management education and support. The app includes 6 features, notably a nutritional logging system with a verified database of Thai and commonly consumed foods, including Asian and Western dishes, as well as blood glucose monitoring, exercise and medication tracking, symptom screening, and weight logging. The primary outcome was HbA1c level, and secondary outcomes included fasting plasma glucose (FPG), low-density lipoprotein cholesterol, estimated glomerular filtration rate, BMI, self-care behaviors, and user satisfaction with the app. The study was conducted between November 29, 2023, and October 30, 2024.</p><p><strong>Results: </strong>A total of 129 participants were randomized (intervention: n=64, 49.6%; control: n=65, 50.4%). Participants in the intervention group were younger (mean age 54.6, SD 14.3 years vs 61.9, SD 12.0 years; P=.002), whereas baseline HbA1c (mean 9.3%, SD 1.96%) and FPG (mean 179.5, SD 5.9 mg/dL) levels were similar between the groups. Over 6 months, the intervention group showed a greater HbA1c reduction than the control group (mean difference -0.24%), but the difference was not statistically significant (P=.13). Among participants aged <65 years, FPG at 6 months was significantly lower in the intervention group (mean difference -29.3 mg/dL; P=.03). App satisfaction was rated as moderate.</p><p><strong>Conclusions: </strong>The mobile app achieved glycemic control comparable to that achieved through standard care, with significant improvement in FPG among participants younger than 65 years. Tailor-made apps integrating regionally relevant dietary content may support effective self-management in type 2 diabetes and warrant further evaluation in larger, long-term studies.</p>","PeriodicalId":52371,"journal":{"name":"JMIR Diabetes","volume":"10 ","pages":"e83685"},"PeriodicalIF":2.6,"publicationDate":"2025-12-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12747420/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145858858","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Akira Kimura, Shinobu Onozawa, Takayuki Ogiwara, Marwan El Ghoch
<p><strong>Background: </strong>Primary care diabetes management lacks objective, scalable methods for continuous physical activity surveillance. Bioelectrical impedance analysis (BIA), routinely collected in diabetes care, offers untapped potential as an automated digital biomarker but requires validation for behavioral phenotyping.</p><p><strong>Objective: </strong>This study aims to evaluate the feasibility and predictive validity of multifrequency bioimpedance for physical activity detection and its association with glycemic control in type 2 diabetes.</p><p><strong>Methods: </strong>This was a pragmatic quasi-experimental study using temporal allocation across three 4-month periods (January 2021-July 2023) in a Japanese primary care clinic, including comprehensive tracking with BIA-guided counseling (n=65), partial tracking (n=31), and standard care (n=100). Adults with type 2 diabetes (hemoglobin A1c [HbA1c] 7.0%-10.0%) underwent monthly segmental multifrequency BIA. The primary outcome was HbA1c <7% at 4 months. Intervention-outcome associations were examined using chi-square trend tests and multivariable logistic regression adjusted for baseline HbA1c, the Walk Score (0-100), and medication indicators. To assess temporal confounding, we conducted ANCOVA on 4-month HbA1c with baseline adjustment (age and BMI added in sensitivity analyses). Effect modification by built environment was tested via Walk Score×Intervention interaction. Predictive validity of left-arm 50-kHz reactance was assessed using area under receiver operating characteristic curve with 95% CI via 10-fold cross-validation.</p><p><strong>Results: </strong>Among 196 participants, the baseline characteristics (age, BMI, HbA1c, diabetes duration, and medications) did not differ across periods (all P>.05). HbA1c <7% achievement showed a gradient: 80% (52/65) comprehensive, 58% (18/31) partial, and 56% (56/100) standard care (χ²4 for trend=14.23; P<.001). ANCOVA of 4-month HbA1c (baseline-adjusted) showed no linear period trend (P=.25). A significant Walk Score×Intervention interaction was observed (β per 10-point Walk Score=-.55; 95% CI -1.03 to -0.06; P=.028), indicating differential effectiveness by neighborhood walkability. Left-arm 50-kHz reactance predicted target achievement (adjusted odds ratio per 1-SD increase =3.04; 95% CI 1.86-4.97; P<.001; area under receiver operating characteristic curve=0.847, 95% CI 0.784-0.910). Among achievers, reactance change correlated with HbA1c change (r=-0.392; P=.032) but not among nonachievers (r=-0.089; P=.54). After the inverse probability weighting was stabilized, each 1-SD increase in left-arm reactance was associated with a 12.1 percentage-point higher probability of target achievement (95% CI 5.2%-19.0%).</p><p><strong>Conclusions: </strong>This pragmatic implementation study demonstrates that automated BIA is feasible for routine diabetes care and suggests potential as a digital biomarker of activity-related glycemic control. Whi
{"title":"Digital Bioimpedance for Physical Activity Detection in Type-2 Diabetes: Quasi-Experimental Validation Study.","authors":"Akira Kimura, Shinobu Onozawa, Takayuki Ogiwara, Marwan El Ghoch","doi":"10.2196/83768","DOIUrl":"10.2196/83768","url":null,"abstract":"<p><strong>Background: </strong>Primary care diabetes management lacks objective, scalable methods for continuous physical activity surveillance. Bioelectrical impedance analysis (BIA), routinely collected in diabetes care, offers untapped potential as an automated digital biomarker but requires validation for behavioral phenotyping.</p><p><strong>Objective: </strong>This study aims to evaluate the feasibility and predictive validity of multifrequency bioimpedance for physical activity detection and its association with glycemic control in type 2 diabetes.</p><p><strong>Methods: </strong>This was a pragmatic quasi-experimental study using temporal allocation across three 4-month periods (January 2021-July 2023) in a Japanese primary care clinic, including comprehensive tracking with BIA-guided counseling (n=65), partial tracking (n=31), and standard care (n=100). Adults with type 2 diabetes (hemoglobin A1c [HbA1c] 7.0%-10.0%) underwent monthly segmental multifrequency BIA. The primary outcome was HbA1c <7% at 4 months. Intervention-outcome associations were examined using chi-square trend tests and multivariable logistic regression adjusted for baseline HbA1c, the Walk Score (0-100), and medication indicators. To assess temporal confounding, we conducted ANCOVA on 4-month HbA1c with baseline adjustment (age and BMI added in sensitivity analyses). Effect modification by built environment was tested via Walk Score×Intervention interaction. Predictive validity of left-arm 50-kHz reactance was assessed using area under receiver operating characteristic curve with 95% CI via 10-fold cross-validation.</p><p><strong>Results: </strong>Among 196 participants, the baseline characteristics (age, BMI, HbA1c, diabetes duration, and medications) did not differ across periods (all P>.05). HbA1c <7% achievement showed a gradient: 80% (52/65) comprehensive, 58% (18/31) partial, and 56% (56/100) standard care (χ²4 for trend=14.23; P<.001). ANCOVA of 4-month HbA1c (baseline-adjusted) showed no linear period trend (P=.25). A significant Walk Score×Intervention interaction was observed (β per 10-point Walk Score=-.55; 95% CI -1.03 to -0.06; P=.028), indicating differential effectiveness by neighborhood walkability. Left-arm 50-kHz reactance predicted target achievement (adjusted odds ratio per 1-SD increase =3.04; 95% CI 1.86-4.97; P<.001; area under receiver operating characteristic curve=0.847, 95% CI 0.784-0.910). Among achievers, reactance change correlated with HbA1c change (r=-0.392; P=.032) but not among nonachievers (r=-0.089; P=.54). After the inverse probability weighting was stabilized, each 1-SD increase in left-arm reactance was associated with a 12.1 percentage-point higher probability of target achievement (95% CI 5.2%-19.0%).</p><p><strong>Conclusions: </strong>This pragmatic implementation study demonstrates that automated BIA is feasible for routine diabetes care and suggests potential as a digital biomarker of activity-related glycemic control. Whi","PeriodicalId":52371,"journal":{"name":"JMIR Diabetes","volume":"10 ","pages":"e83768"},"PeriodicalIF":2.6,"publicationDate":"2025-12-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12707439/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145769967","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Cassie D Turner, Kishor Patel, Katherine Freeman, Lyndsay Ruff, Jamie Michaels, Timothy Bodnar, Laura R Saslow, James Henderson, Lauren Oshman, Caroline R Richardson, Devvrat Malhotra, A Mark Fendrick, Garth Strohbehn, Dina H Griauzde
<p><strong>Background: </strong>One in 4 Veterans who receive care through the Veterans Health Administration has type 2 diabetes (T2D). Dietary carbohydrate restriction can promote weight loss and improve blood glucose control, but Veterans taking certain medications (eg, insulin) may experience serious complications (eg, hypoglycemia) without adequate support and monitoring.</p><p><strong>Objective: </strong>This study aims to develop and evaluate the feasibility, acceptability, and clinical effectiveness of a pilot low-carbohydrate (LC) nutrition counseling program guided by continuous glucose monitoring (CGM) for Veterans with T2D receiving insulin (ie, LC-CGM).</p><p><strong>Methods: </strong>This is a pragmatic, nonrandomized, pre-post quality improvement pilot program. Eligible patients were Veterans with T2D who were prescribed ≥3 daily injections of insulin. The 24-week LC-CGM program consisted of virtual visits with a registered dietitian (RD) and clinical pharmacy practitioner (CPP); CGM data were used to guide tailored nutrition counseling and de-escalation or cessation of glucose-lowering medications. To evaluate changes from baseline, intention-to-treat analyses were conducted for all enrollees, with separate analyses for program completers. Primary outcomes were program feasibility and acceptability (ie, program enrollment and completion rates and mean number of RD and CPP visits). Secondary outcomes included mean weight change, percent weight loss, achievement of ≥5% and ≥10% weight loss, change in glucose-lowering medication use, and change in laboratory measures (eg, hemoglobin A1c [HbA1c]).</p><p><strong>Results: </strong>Program evaluation occurred from March 19, 2021, to May 3, 2024. Among 43 Veterans referred to the LC-CGM program, 38 (88%) enrolled. Most were men (37/38, 97%), white (29/38, 76%), with an average age of 63.7 (SD 9.6) years. Mean BMI and HbA1c were 38.1 (SD 5.8) kg/m2 and 7.8% (SD 1.3). Of 38 enrollees, 27 (71%) completed the program. Enrollees averaged 9.5 (SD 3.3) RD visits and 12.8 (SD 4.7) CPP visits. In intention-to-treat analyses, mean weight change was -11.5 kilograms (SD 8.7; 95% CI -14.4 to -8.6), corresponding to 9.5% weight loss (SD 7.2; 95% CI -14.9 to -4.2), with 58% (22/38) achieving ≥5% weight loss and 32% (12/38) achieving ≥10% weight loss. Overall, use of glucose-lowering medications decreased from 3.5 (SD 0.8) per patient at baseline to 2.4 (SD 0.9) per patient at 24 weeks (P<.001), with 72% (26/36) of Veterans discontinuing short-acting insulin and 50% (18/36; P<.001) discontinuing long-acting insulin. Use of glucagon-like peptide-1 receptor agonists increased from 39% (15/38) at baseline to 61% (23/38) at 24 weeks (P=.02). Among program completers (n=27), mean percent weight loss was -11.8% (SD 6.5) and median HbA1c decreased by 0.7% (95% CI -0.9 to -0.3; P=.001).</p><p><strong>Conclusions: </strong>This pilot program provides preliminary evidence that supports feasibility, acceptability,
背景:四分之一接受退伍军人健康管理局护理的退伍军人患有2型糖尿病(T2D)。饮食碳水化合物限制可以促进减肥和改善血糖控制,但退伍军人服用某些药物(如胰岛素)可能会遇到严重的并发症(如低血糖),没有足够的支持和监测。目的:本研究旨在为接受胰岛素治疗的t2dm退伍军人(即LC-CGM)制定并评估以连续血糖监测(CGM)为指导的低碳水化合物(LC)营养咨询试点方案的可行性、可接受性和临床效果。方法:这是一个务实的、非随机的、岗前质量改进试点项目。符合条件的患者是患有T2D的退伍军人,每天注射胰岛素≥3次。为期24周的LC-CGM计划包括与注册营养师(RD)和临床药学从业者(CPP)进行虚拟访问;CGM数据用于指导量身定制的营养咨询和降糖药物的降级或停止。为了评估从基线开始的变化,对所有入组者进行意向治疗分析,并对项目完成者进行单独分析。主要结果是项目的可行性和可接受性(即项目的入组率和完成率以及RD和CPP就诊的平均次数)。次要结局包括平均体重变化、体重减轻百分比、体重减轻≥5%和≥10%、降糖药物使用的变化和实验室测量的变化(如血红蛋白A1c [HbA1c])。结果:项目评估时间为2021年3月19日至2024年5月3日。在参与LC-CGM项目的43名退伍军人中,38人(88%)注册。多数为男性(37/ 38,97%),白人(29/ 38,76%),平均年龄63.7岁(SD 9.6)。平均BMI和HbA1c分别为38.1 (SD 5.8) kg/m2和7.8% (SD 1.3)。在38名参与者中,27人(71%)完成了该项目。受试者平均RD访问9.5次(SD 3.3), CPP访问12.8次(SD 4.7)。在意向治疗分析中,平均体重变化为-11.5 kg (SD 8.7; 95% CI -14.4至-8.6),相当于体重减轻9.5% (SD 7.2; 95% CI -14.9至-4.2),其中58%(22/38)达到体重减轻≥5%,32%(12/38)达到体重减轻≥10%。总体而言,降糖药物的使用从基线时的每名患者3.5 (SD 0.8)下降到24周时的每名患者2.4 (SD 0.9)。结论:该试点项目为t2dm退伍军人的可行性、可接受性和临床有效性提供了初步证据。需要进一步的研究来严格测试更大的符合条件的退伍军人群体的长期临床和成本效益。
{"title":"Low-Carbohydrate Nutrition Counseling With Continuous Glucose Monitoring to Improve Metabolic Health Among Veterans With Type 2 Diabetes: Pilot Quality Improvement Initiative Study.","authors":"Cassie D Turner, Kishor Patel, Katherine Freeman, Lyndsay Ruff, Jamie Michaels, Timothy Bodnar, Laura R Saslow, James Henderson, Lauren Oshman, Caroline R Richardson, Devvrat Malhotra, A Mark Fendrick, Garth Strohbehn, Dina H Griauzde","doi":"10.2196/75672","DOIUrl":"10.2196/75672","url":null,"abstract":"<p><strong>Background: </strong>One in 4 Veterans who receive care through the Veterans Health Administration has type 2 diabetes (T2D). Dietary carbohydrate restriction can promote weight loss and improve blood glucose control, but Veterans taking certain medications (eg, insulin) may experience serious complications (eg, hypoglycemia) without adequate support and monitoring.</p><p><strong>Objective: </strong>This study aims to develop and evaluate the feasibility, acceptability, and clinical effectiveness of a pilot low-carbohydrate (LC) nutrition counseling program guided by continuous glucose monitoring (CGM) for Veterans with T2D receiving insulin (ie, LC-CGM).</p><p><strong>Methods: </strong>This is a pragmatic, nonrandomized, pre-post quality improvement pilot program. Eligible patients were Veterans with T2D who were prescribed ≥3 daily injections of insulin. The 24-week LC-CGM program consisted of virtual visits with a registered dietitian (RD) and clinical pharmacy practitioner (CPP); CGM data were used to guide tailored nutrition counseling and de-escalation or cessation of glucose-lowering medications. To evaluate changes from baseline, intention-to-treat analyses were conducted for all enrollees, with separate analyses for program completers. Primary outcomes were program feasibility and acceptability (ie, program enrollment and completion rates and mean number of RD and CPP visits). Secondary outcomes included mean weight change, percent weight loss, achievement of ≥5% and ≥10% weight loss, change in glucose-lowering medication use, and change in laboratory measures (eg, hemoglobin A1c [HbA1c]).</p><p><strong>Results: </strong>Program evaluation occurred from March 19, 2021, to May 3, 2024. Among 43 Veterans referred to the LC-CGM program, 38 (88%) enrolled. Most were men (37/38, 97%), white (29/38, 76%), with an average age of 63.7 (SD 9.6) years. Mean BMI and HbA1c were 38.1 (SD 5.8) kg/m2 and 7.8% (SD 1.3). Of 38 enrollees, 27 (71%) completed the program. Enrollees averaged 9.5 (SD 3.3) RD visits and 12.8 (SD 4.7) CPP visits. In intention-to-treat analyses, mean weight change was -11.5 kilograms (SD 8.7; 95% CI -14.4 to -8.6), corresponding to 9.5% weight loss (SD 7.2; 95% CI -14.9 to -4.2), with 58% (22/38) achieving ≥5% weight loss and 32% (12/38) achieving ≥10% weight loss. Overall, use of glucose-lowering medications decreased from 3.5 (SD 0.8) per patient at baseline to 2.4 (SD 0.9) per patient at 24 weeks (P<.001), with 72% (26/36) of Veterans discontinuing short-acting insulin and 50% (18/36; P<.001) discontinuing long-acting insulin. Use of glucagon-like peptide-1 receptor agonists increased from 39% (15/38) at baseline to 61% (23/38) at 24 weeks (P=.02). Among program completers (n=27), mean percent weight loss was -11.8% (SD 6.5) and median HbA1c decreased by 0.7% (95% CI -0.9 to -0.3; P=.001).</p><p><strong>Conclusions: </strong>This pilot program provides preliminary evidence that supports feasibility, acceptability, ","PeriodicalId":52371,"journal":{"name":"JMIR Diabetes","volume":"10 ","pages":"e75672"},"PeriodicalIF":2.6,"publicationDate":"2025-12-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12705128/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145764416","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Ida Ayu Made Kshanti, Nadya Magfira, Anak Agung Arie Widyastuti, Jerry Nasarudin, Marina Epriliawati, Md Ikhsan Mokoagow
Background: Insulin therapy is crucial for managing type 2 diabetes mellitus, with its use steadily increasing in Indonesia and its effectiveness well established. However, prescribing insulin poses various challenges that can impact the effectiveness of insulin. Patient education is crucial for the successful implementation of insulin therapy. Proper insulin use remains insufficient in Indonesia.
Objective: This study aims to investigate physicians' knowledge and practice in providing education on insulin use to patients with type 2 diabetes mellitus in Indonesia.
Methods: This study recruited potential participants (all physicians in Indonesia) through the internet using a convenience sampling method. The participants were asked to fill out a questionnaire. The questionnaire had 32 questions divided into 4 sections: demographics and clinical practice, practice of insulin education, the Indonesian insulin injection technique guideline, and knowledge of insulin injection techniques. The instrument used in this study was developed based on the Pedoman Teknik Menyuntik Insulin Indonesia, which was adapted from the international consensus by the Forum for Injection Technique and Therapy Expert Recommendations. The survey lasted from February 2021 to March 2021. Data were analyzed using the Kruskal-Wallis tests.
Results: A total of 823 participants were included in the analysis. Out of 823 participants, 680 (82.6%) had given insulin education to patients at least once during the last 30 days. However, out of 823 participants, only 479 (58.2%) used specific guidelines in their practice, with only 280 (34.0%) aware of the Indonesian guidelines. Out of 823 participants, 815 (99.1%) agreed that insulin injection techniques would affect clinical results. The median score of knowledge about insulin injection techniques was 7 (IQR 2) among the study participants, indicating good knowledge. Profession was the only variable significantly associated with knowledge scores, with consultants in endocrinology, metabolism, and diabetes achieving the highest median scores, and other physicians the lowest (P<.001).
Conclusions: Most physicians in this study reported providing education to their patients. However, there was still a gap between the guidelines and the practice of insulin education, as indicated by the lack of awareness and a fair level of knowledge about the Indonesian guidelines.
背景:胰岛素治疗对2型糖尿病的治疗至关重要,在印度尼西亚胰岛素的使用稳步增加,其有效性也得到了很好的证实。然而,处方胰岛素带来了各种各样的挑战,可能会影响胰岛素的有效性。患者教育对于胰岛素治疗的成功实施至关重要。在印度尼西亚,适当的胰岛素使用仍然不足。目的:了解印尼医生对2型糖尿病患者进行胰岛素使用教育的知识和实践情况。方法:本研究采用方便的抽样方法,通过互联网招募潜在的参与者(印度尼西亚的所有医生)。参与者被要求填写一份问卷。问卷共32题,分为人口统计学与临床实践、胰岛素教育实践、印尼胰岛素注射技术指南、胰岛素注射技术知识4个部分。本研究中使用的仪器是根据印度尼西亚的Pedoman Teknik Menyuntik胰岛素开发的,该胰岛素是根据注射技术和治疗专家建议论坛的国际共识改编的。该调查从2021年2月持续到2021年3月。使用Kruskal-Wallis检验分析数据。结果:共纳入823名参与者。在823名参与者中,680名(82.6%)在过去30天内至少对患者进行过一次胰岛素教育。然而,在823名参与者中,只有479人(58.2%)在实践中使用了具体的指导方针,只有280人(34.0%)知道印度尼西亚的指导方针。在823名参与者中,815人(99.1%)同意胰岛素注射技术会影响临床结果。研究对象对胰岛素注射技术知识的中位数得分为7分(IQR 2),表明知识较好。职业是唯一与知识得分显著相关的变量,内分泌科、代谢科和糖尿病科的咨询师的中位数得分最高,而其他医生的中位数得分最低(结论:本研究中大多数医生报告向患者提供教育。但是,指南与胰岛素教育的实践之间仍然存在差距,这表明缺乏对印度尼西亚指南的认识和相当程度的知识。
{"title":"Insulin Injection Technique Education and Associated Knowledge Factors Among Physicians: Cross-Sectional Survey Study.","authors":"Ida Ayu Made Kshanti, Nadya Magfira, Anak Agung Arie Widyastuti, Jerry Nasarudin, Marina Epriliawati, Md Ikhsan Mokoagow","doi":"10.2196/65359","DOIUrl":"10.2196/65359","url":null,"abstract":"<p><strong>Background: </strong>Insulin therapy is crucial for managing type 2 diabetes mellitus, with its use steadily increasing in Indonesia and its effectiveness well established. However, prescribing insulin poses various challenges that can impact the effectiveness of insulin. Patient education is crucial for the successful implementation of insulin therapy. Proper insulin use remains insufficient in Indonesia.</p><p><strong>Objective: </strong>This study aims to investigate physicians' knowledge and practice in providing education on insulin use to patients with type 2 diabetes mellitus in Indonesia.</p><p><strong>Methods: </strong>This study recruited potential participants (all physicians in Indonesia) through the internet using a convenience sampling method. The participants were asked to fill out a questionnaire. The questionnaire had 32 questions divided into 4 sections: demographics and clinical practice, practice of insulin education, the Indonesian insulin injection technique guideline, and knowledge of insulin injection techniques. The instrument used in this study was developed based on the Pedoman Teknik Menyuntik Insulin Indonesia, which was adapted from the international consensus by the Forum for Injection Technique and Therapy Expert Recommendations. The survey lasted from February 2021 to March 2021. Data were analyzed using the Kruskal-Wallis tests.</p><p><strong>Results: </strong>A total of 823 participants were included in the analysis. Out of 823 participants, 680 (82.6%) had given insulin education to patients at least once during the last 30 days. However, out of 823 participants, only 479 (58.2%) used specific guidelines in their practice, with only 280 (34.0%) aware of the Indonesian guidelines. Out of 823 participants, 815 (99.1%) agreed that insulin injection techniques would affect clinical results. The median score of knowledge about insulin injection techniques was 7 (IQR 2) among the study participants, indicating good knowledge. Profession was the only variable significantly associated with knowledge scores, with consultants in endocrinology, metabolism, and diabetes achieving the highest median scores, and other physicians the lowest (P<.001).</p><p><strong>Conclusions: </strong>Most physicians in this study reported providing education to their patients. However, there was still a gap between the guidelines and the practice of insulin education, as indicated by the lack of awareness and a fair level of knowledge about the Indonesian guidelines.</p>","PeriodicalId":52371,"journal":{"name":"JMIR Diabetes","volume":"10 ","pages":"e65359"},"PeriodicalIF":2.6,"publicationDate":"2025-12-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12685283/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145710005","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Unlabelled: We developed an innovative bilingual toolkit comprising a personalized action plan and educational videos to encourage insulin dose self-titration by adults living with type 2 diabetes.
{"title":"An Innovative Insulin Dose Self-Titration Toolkit for Adults Living With Type 2 Diabetes Mellitus.","authors":"Nadin Abbas, Heather Lochnan, Sandhya Goge, Annie Garon-Mailer, Cathy J Sun","doi":"10.2196/75903","DOIUrl":"10.2196/75903","url":null,"abstract":"<p><strong>Unlabelled: </strong>We developed an innovative bilingual toolkit comprising a personalized action plan and educational videos to encourage insulin dose self-titration by adults living with type 2 diabetes.</p>","PeriodicalId":52371,"journal":{"name":"JMIR Diabetes","volume":"10 ","pages":"e75903"},"PeriodicalIF":2.6,"publicationDate":"2025-11-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12661589/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145642647","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Daniel Gasca Garcia, Hood Thabit, Paul W Nutter, Simon Harper
Background: Basal rate (BR) adjustment is crucial for managing type 1 diabetes mellitus, accounting for 30% to 50% of total daily insulin needs. All current closed-loop systems revert to the user's usual pump BR (known as manual mode) in the event of closed loop failure. Furthermore, access to closed-loop systems remains relatively low in low- and middle-income countries and among those without suitable health insurance. Accurately adjusting the BR remains challenging, leading to hypo- or hyperglycemia, and research on optimizing the BR is limited.
Objective: This study proposed an adaptive algorithm that uses continuous glucose monitoring data to identify BR inaccuracies without requiring meal intake information.
Methods: The OhioT1DM dataset formed the basis for implementing this methodology. Each composite day was generated by excluding bolus insulin profiles lacking meal intake information and by calculating hourly blood glucose (BG) relative levels along with their corresponding reliability measures, enabling assessment of deviations from the recommended BR (ie, a BG relative change of 0 mg/dL). Both a noninferiority analysis and a classification precision metric were used to assess the practicality of this approach compared to using meal data.
Results: Data from 12 participants showed noninferiority of the no-meal method: using a 20% noninferiority margin on absolute BG relative change, 9 of 12 participants met the criterion (1-sided P<.05). Classification precision was 73.9% (139/188) of meals correctly classified on average per participant (SD 11.8%; 95% CI 67.2%-79.7%). The daily cumulative BG average was 200.6 mg/dL (SD 61.7 mg/dL; 11.1 mmol/L, SD 3.4 mmol/L; 95% CI 161.4-239.8 mg/dL), with peak values reaching 270.15 mg/dL (14.99 mmol/L). Furthermore, 99.3% (286/288) of the BG relative values (SD 0.5%; 95% CI 97.5%-99.8%) that were unaffected by external factors were associated with incorrect BR settings, with deviations ranging from -25.5 to 46 mg/dL (-1.58 to 2.59 mmol/L).
Conclusions: Current strategies to optimize BR settings are inadequate, and our approach of a personalized basal tuner (PBT) helps better analyze BR without relying on meal intake information. Indeed, without an optimally set BR, in the event of the closed loop reverting to manual mode, patients may be exposed to persistent hypo- or hyperglycemia, leading to safety and efficacy issues. Future work will focus on generating BR recommendations through the application of this algorithm in clinical practice to assist clinicians in setting BR in low- and middle-income countries, where closed-loop systems are not prevalent, to help increase time in range.
{"title":"Toward a Personalized Basal Tuner for Detecting Basal Rate Inaccuracies in Type 1 Diabetes Mellitus Without Meal Data: Algorithm Development and Retrospective Validation Study.","authors":"Daniel Gasca Garcia, Hood Thabit, Paul W Nutter, Simon Harper","doi":"10.2196/72769","DOIUrl":"10.2196/72769","url":null,"abstract":"<p><strong>Background: </strong>Basal rate (BR) adjustment is crucial for managing type 1 diabetes mellitus, accounting for 30% to 50% of total daily insulin needs. All current closed-loop systems revert to the user's usual pump BR (known as manual mode) in the event of closed loop failure. Furthermore, access to closed-loop systems remains relatively low in low- and middle-income countries and among those without suitable health insurance. Accurately adjusting the BR remains challenging, leading to hypo- or hyperglycemia, and research on optimizing the BR is limited.</p><p><strong>Objective: </strong>This study proposed an adaptive algorithm that uses continuous glucose monitoring data to identify BR inaccuracies without requiring meal intake information.</p><p><strong>Methods: </strong>The OhioT1DM dataset formed the basis for implementing this methodology. Each composite day was generated by excluding bolus insulin profiles lacking meal intake information and by calculating hourly blood glucose (BG) relative levels along with their corresponding reliability measures, enabling assessment of deviations from the recommended BR (ie, a BG relative change of 0 mg/dL). Both a noninferiority analysis and a classification precision metric were used to assess the practicality of this approach compared to using meal data.</p><p><strong>Results: </strong>Data from 12 participants showed noninferiority of the no-meal method: using a 20% noninferiority margin on absolute BG relative change, 9 of 12 participants met the criterion (1-sided P<.05). Classification precision was 73.9% (139/188) of meals correctly classified on average per participant (SD 11.8%; 95% CI 67.2%-79.7%). The daily cumulative BG average was 200.6 mg/dL (SD 61.7 mg/dL; 11.1 mmol/L, SD 3.4 mmol/L; 95% CI 161.4-239.8 mg/dL), with peak values reaching 270.15 mg/dL (14.99 mmol/L). Furthermore, 99.3% (286/288) of the BG relative values (SD 0.5%; 95% CI 97.5%-99.8%) that were unaffected by external factors were associated with incorrect BR settings, with deviations ranging from -25.5 to 46 mg/dL (-1.58 to 2.59 mmol/L).</p><p><strong>Conclusions: </strong>Current strategies to optimize BR settings are inadequate, and our approach of a personalized basal tuner (PBT) helps better analyze BR without relying on meal intake information. Indeed, without an optimally set BR, in the event of the closed loop reverting to manual mode, patients may be exposed to persistent hypo- or hyperglycemia, leading to safety and efficacy issues. Future work will focus on generating BR recommendations through the application of this algorithm in clinical practice to assist clinicians in setting BR in low- and middle-income countries, where closed-loop systems are not prevalent, to help increase time in range.</p>","PeriodicalId":52371,"journal":{"name":"JMIR Diabetes","volume":"10 ","pages":"e72769"},"PeriodicalIF":2.6,"publicationDate":"2025-11-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12661609/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145642680","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Nicole Lubasinski, Hood Thabit, Paul W Nutter, David Petrescu, Simon Harper
Background: Managing type 1 diabetes (T1D) requires maintaining target blood glucose levels through precise diet and insulin dosing. Predicting postprandial glycemic responses (PPGRs) based solely on carbohydrate content is limited by factors such as meal composition, individual physiology, and lifestyle. Continuous glucose monitors provide insights into these responses, revealing significant individual variability. The statistical clustering method proposed here balances the number of clusters formed and the glycemic variability of the PPGRs within each cluster to offer a clustering technique on which treatment decisions could be based.
Objective: This study aims to develop and evaluate a PPGR clustering method that identifies reproducible meal-specific glucose patterns in people with type 1 diabetes.
Methods: Blood glucose data from the OhioT1DM dataset were used to assess clustering of PPGR based on the coefficient of variability (CV) of glucose. Clustering was performed using statistical clustering, with each PPGR isolated into 48 data points per event. A CV threshold of <36% was used to define clinically similar clusters. This aimed to cluster PPGRs with minimal glycemic variability. The approach aims to enhance precision in analyzing postprandial glycemic dynamics, assessing cluster cohesion via standard deviation and CV within meal categories.
Results: The analysis revealed a reproducible set of PPGR clusters specific to meal types and individuals (mean [SD], 2.4 [1.8] for breakfast, 2.7 [0.9] for lunch, and 3.1 [1.0] for dinner), with the number of clusters varying across participants and meals in the dataset. Carbohydrate intake alone did not affect cluster formation, suggesting a complex relationship between meal composition and PPGR variability. However, certain individuals showed significant associations between carbohydrate intake and cluster formation for specific meals.
Conclusions: The meal-based glycemic clustering algorithm provides a promising framework for predicting PPGRs in people with type 1 diabetes, independent of carbohydrate intake. It emphasizes the need for personalized prediction models to optimize time in range and enhance diabetes management. Efforts to refine treatment strategies are crucial in reducing T1D-related complications.
{"title":"Coefficient of Variation to Assess the Reproducibility of Meal-Induced Glycemic Responses: Development of a Clustering Algorithm.","authors":"Nicole Lubasinski, Hood Thabit, Paul W Nutter, David Petrescu, Simon Harper","doi":"10.2196/68821","DOIUrl":"10.2196/68821","url":null,"abstract":"<p><strong>Background: </strong>Managing type 1 diabetes (T1D) requires maintaining target blood glucose levels through precise diet and insulin dosing. Predicting postprandial glycemic responses (PPGRs) based solely on carbohydrate content is limited by factors such as meal composition, individual physiology, and lifestyle. Continuous glucose monitors provide insights into these responses, revealing significant individual variability. The statistical clustering method proposed here balances the number of clusters formed and the glycemic variability of the PPGRs within each cluster to offer a clustering technique on which treatment decisions could be based.</p><p><strong>Objective: </strong>This study aims to develop and evaluate a PPGR clustering method that identifies reproducible meal-specific glucose patterns in people with type 1 diabetes.</p><p><strong>Methods: </strong>Blood glucose data from the OhioT1DM dataset were used to assess clustering of PPGR based on the coefficient of variability (CV) of glucose. Clustering was performed using statistical clustering, with each PPGR isolated into 48 data points per event. A CV threshold of <36% was used to define clinically similar clusters. This aimed to cluster PPGRs with minimal glycemic variability. The approach aims to enhance precision in analyzing postprandial glycemic dynamics, assessing cluster cohesion via standard deviation and CV within meal categories.</p><p><strong>Results: </strong>The analysis revealed a reproducible set of PPGR clusters specific to meal types and individuals (mean [SD], 2.4 [1.8] for breakfast, 2.7 [0.9] for lunch, and 3.1 [1.0] for dinner), with the number of clusters varying across participants and meals in the dataset. Carbohydrate intake alone did not affect cluster formation, suggesting a complex relationship between meal composition and PPGR variability. However, certain individuals showed significant associations between carbohydrate intake and cluster formation for specific meals.</p><p><strong>Conclusions: </strong>The meal-based glycemic clustering algorithm provides a promising framework for predicting PPGRs in people with type 1 diabetes, independent of carbohydrate intake. It emphasizes the need for personalized prediction models to optimize time in range and enhance diabetes management. Efforts to refine treatment strategies are crucial in reducing T1D-related complications.</p>","PeriodicalId":52371,"journal":{"name":"JMIR Diabetes","volume":"10 ","pages":"e68821"},"PeriodicalIF":2.6,"publicationDate":"2025-11-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12633838/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145566105","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Flavia Voiculescu, Paul Darvasi, Esli Osmanlliu, Preetha Krishnamoorthy, Angeliki Makri
Unlabelled: Diabetes self-management plays a major role in controlling blood sugar levels and avoiding chronic complications. In this report, we investigate the strengths and limitations of artificial intelligence chatbots in supporting patients with type 1 diabetes and their families. With the growing accessibility of these constantly evolving tools, front-line providers must advocate for their responsible use.
{"title":"Natural Language AI Models and Pediatric Type 1 Diabetes: Can Chatbots Help With Diabetes Self-Management and Patient Education?","authors":"Flavia Voiculescu, Paul Darvasi, Esli Osmanlliu, Preetha Krishnamoorthy, Angeliki Makri","doi":"10.2196/76986","DOIUrl":"10.2196/76986","url":null,"abstract":"<p><strong>Unlabelled: </strong>Diabetes self-management plays a major role in controlling blood sugar levels and avoiding chronic complications. In this report, we investigate the strengths and limitations of artificial intelligence chatbots in supporting patients with type 1 diabetes and their families. With the growing accessibility of these constantly evolving tools, front-line providers must advocate for their responsible use.</p>","PeriodicalId":52371,"journal":{"name":"JMIR Diabetes","volume":"10 ","pages":"e76986"},"PeriodicalIF":2.6,"publicationDate":"2025-11-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12594437/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145471974","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Abdulrahman M Elnasieh, Mohammed Almesned, Akram N Al Hazmi, Atheer Alturki, Faisal I Alhawaidi, Razan K Alhadlq, Maryam Alramadhan, Nasser Alobilan, Yasser Sheikh Qroosh
Background: The escalating rates of obesity and type 2 diabetes mellitus (T2DM) in Saudi Arabia highlight the impending burden of metabolic dysfunction-associated steatotic liver disease (MASLD) and nonalcoholic steatohepatitis.
Objective: This study aimed to identify MASLD among patients with T2DM at King Saud Medical City family medicine clinics, Riyadh, and explore associated factors to facilitate early intervention and prevention strategies.
Methods: This cross-sectional study identified patients with T2DM who attended King Saud Medical City, Riyadh, underwent an abdominal ultrasound, and were diagnosed with MASLD. The study data were collected by a peer-reviewed validated data extraction sheet and analyzed by SPSS (version 26.0; IBM Corp).
Results: Our study included 292 participants, with 47.3% (n=138) males and 52.7% (n=154) females. Notably, the prevalence of MASLD was 54.5% (n=159). Prevalent comorbidities included dyslipidemia (218/292, 74.7%) and hypertension (209/292, 71.6%). Most participants were nonsmokers (218/292, 74.7%). Higher waist circumference was significantly associated with MASLD (P=.02), with >80 cm among females (85/141, 60.3%) and >94 cm among males (60/141, 54.5%) affected across different stages of MASLD. Obesity (BMI>30 kg/m2) also significantly correlated with MASLD (P<.001). Individuals taking aspirin had half the odds of MASLD development (odds ratio [OR] 0.523, 95% CI 0.331-0.844; P=.007). Biochemical analysis revealed significant associations between MASLD and elevated alanine aminotransferase (P=.009), aspartate aminotransferase (P=.01), and homeostatic model assessment of insulin resistance (P=.001). Total cholesterol (P=.01), triglycerides (P=.03), and low-density lipoprotein (P=.04) were significantly elevated in patients with MASLD. Insulin exhibited a significant positive correlation with MASLD (r=0.24; P=.001). Glucose levels showed no significant association (r=0.03; P=.63).
Conclusions: Our study highlights significant associations between MASLD and various factors, including waist circumference, obesity, and certain biochemical markers. Furthermore, the protective effect of aspirin against MASLD warrants further investigation. These findings underscore the importance of early intervention and targeted preventive strategies.
{"title":"Prevalence and Risk Factors of Metabolic Dysfunction-Associated Steatotic Liver Disease in Patients With Type 2 Diabetes Mellitus at a Tertiary Center in Saudi Arabia: Cross-Sectional Questionnaire Study.","authors":"Abdulrahman M Elnasieh, Mohammed Almesned, Akram N Al Hazmi, Atheer Alturki, Faisal I Alhawaidi, Razan K Alhadlq, Maryam Alramadhan, Nasser Alobilan, Yasser Sheikh Qroosh","doi":"10.2196/77772","DOIUrl":"10.2196/77772","url":null,"abstract":"<p><strong>Background: </strong>The escalating rates of obesity and type 2 diabetes mellitus (T2DM) in Saudi Arabia highlight the impending burden of metabolic dysfunction-associated steatotic liver disease (MASLD) and nonalcoholic steatohepatitis.</p><p><strong>Objective: </strong>This study aimed to identify MASLD among patients with T2DM at King Saud Medical City family medicine clinics, Riyadh, and explore associated factors to facilitate early intervention and prevention strategies.</p><p><strong>Methods: </strong>This cross-sectional study identified patients with T2DM who attended King Saud Medical City, Riyadh, underwent an abdominal ultrasound, and were diagnosed with MASLD. The study data were collected by a peer-reviewed validated data extraction sheet and analyzed by SPSS (version 26.0; IBM Corp).</p><p><strong>Results: </strong>Our study included 292 participants, with 47.3% (n=138) males and 52.7% (n=154) females. Notably, the prevalence of MASLD was 54.5% (n=159). Prevalent comorbidities included dyslipidemia (218/292, 74.7%) and hypertension (209/292, 71.6%). Most participants were nonsmokers (218/292, 74.7%). Higher waist circumference was significantly associated with MASLD (P=.02), with >80 cm among females (85/141, 60.3%) and >94 cm among males (60/141, 54.5%) affected across different stages of MASLD. Obesity (BMI>30 kg/m2) also significantly correlated with MASLD (P<.001). Individuals taking aspirin had half the odds of MASLD development (odds ratio [OR] 0.523, 95% CI 0.331-0.844; P=.007). Biochemical analysis revealed significant associations between MASLD and elevated alanine aminotransferase (P=.009), aspartate aminotransferase (P=.01), and homeostatic model assessment of insulin resistance (P=.001). Total cholesterol (P=.01), triglycerides (P=.03), and low-density lipoprotein (P=.04) were significantly elevated in patients with MASLD. Insulin exhibited a significant positive correlation with MASLD (r=0.24; P=.001). Glucose levels showed no significant association (r=0.03; P=.63).</p><p><strong>Conclusions: </strong>Our study highlights significant associations between MASLD and various factors, including waist circumference, obesity, and certain biochemical markers. Furthermore, the protective effect of aspirin against MASLD warrants further investigation. These findings underscore the importance of early intervention and targeted preventive strategies.</p>","PeriodicalId":52371,"journal":{"name":"JMIR Diabetes","volume":"10 ","pages":"e77772"},"PeriodicalIF":2.6,"publicationDate":"2025-11-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12582413/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145439959","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Denis O'Donnell, Sue Burns, Shirley Drever, Lisa Quesnelle, Benjamin Yuen
<p><strong>Unlabelled: </strong>Despite efforts to raise glycemic targets and reduce modifiable risk factors, hypoglycemia continues to impact a large number of long-term care (LTC) residents living with diabetes mellitus and remains one of the leading causes of hospitalization in this cohort. Effective, sustainable practice strategies to monitor and maintain glycemic control in LTC are lacking. We describe the stepwise approach used by 2 LTC homes that switched from traditional fingerstick testing to a continuous glucose monitoring (CGM) system as part of a quality improvement initiative to reduce nursing workload and address hypoglycemia. This was an exploratory pilot project. A working group was established at each of the 2 participating LTC homes, including representatives from management and direct care staff. Kickoff meetings were held with key direct care staff to discuss the limitations of current monitoring practices and potential solutions. The following interventions were agreed upon and implemented by the working groups: (1) the initiation of structured glucose monitoring for residents using CGM (FreeStyle Libre 2), requiring scanning of sensors 4 times per day; (2) provision of staff education and training on CGM by a diabetes expert; and (3) scheduling of interdisciplinary rounds as needed to optimize diabetes management. System changes were gradually introduced in a stepwise manner over a 3-month period (intervention phase), during which the LTC homes progressed from traditional fingerstick testing to point-of-care sensor readings and then to full use of the CGM software platform. Hypoglycemia was defined as a glucose reading of ≤4 mmol/L. Glucose readings were collected from 38 residents living with diabetes mellitus and receiving insulin in the 6 months before the start of the intervention phase (baseline evaluation) and in the 6 months after the end of the intervention phase (post-launch evaluation). All hypoglycemic readings detected by a sensor at a point-of-care test were validated using a fingerstick test. Nursing workload associated with glucose testing was assessed in an anonymous survey of nursing staff at baseline and after the launch. The approach resulted in a 40% reduction in nursing time required to complete a glucose reading (from 5.1 min per test at baseline to 3.1 min per test at the post-launch evaluation). The frequency of glucose monitoring increased from a total of 19,438 glucose readings in the baseline evaluation to 35,971 point-of-care sensor scans in the post-launch evaluation. The number of detected hypoglycemic events increased 12-fold, from 88 in the baseline evaluation to 1049 in the post-launch evaluation. Hypoglycemic events continue to impact a large number of LTC residents living with diabetes mellitus. CGM can improve the detection of hypoglycemic events while decreasing nursing workload. A gradual transition to CGM can help overcome underlying barriers and concerns and ensure a sustainable approa
{"title":"Revolutionizing Hypoglycemia Management in Long-Term Care: Lessons Learned From a Pilot Quality Improvement Initiative Using Continuous Glucose Monitoring.","authors":"Denis O'Donnell, Sue Burns, Shirley Drever, Lisa Quesnelle, Benjamin Yuen","doi":"10.2196/73485","DOIUrl":"10.2196/73485","url":null,"abstract":"<p><strong>Unlabelled: </strong>Despite efforts to raise glycemic targets and reduce modifiable risk factors, hypoglycemia continues to impact a large number of long-term care (LTC) residents living with diabetes mellitus and remains one of the leading causes of hospitalization in this cohort. Effective, sustainable practice strategies to monitor and maintain glycemic control in LTC are lacking. We describe the stepwise approach used by 2 LTC homes that switched from traditional fingerstick testing to a continuous glucose monitoring (CGM) system as part of a quality improvement initiative to reduce nursing workload and address hypoglycemia. This was an exploratory pilot project. A working group was established at each of the 2 participating LTC homes, including representatives from management and direct care staff. Kickoff meetings were held with key direct care staff to discuss the limitations of current monitoring practices and potential solutions. The following interventions were agreed upon and implemented by the working groups: (1) the initiation of structured glucose monitoring for residents using CGM (FreeStyle Libre 2), requiring scanning of sensors 4 times per day; (2) provision of staff education and training on CGM by a diabetes expert; and (3) scheduling of interdisciplinary rounds as needed to optimize diabetes management. System changes were gradually introduced in a stepwise manner over a 3-month period (intervention phase), during which the LTC homes progressed from traditional fingerstick testing to point-of-care sensor readings and then to full use of the CGM software platform. Hypoglycemia was defined as a glucose reading of ≤4 mmol/L. Glucose readings were collected from 38 residents living with diabetes mellitus and receiving insulin in the 6 months before the start of the intervention phase (baseline evaluation) and in the 6 months after the end of the intervention phase (post-launch evaluation). All hypoglycemic readings detected by a sensor at a point-of-care test were validated using a fingerstick test. Nursing workload associated with glucose testing was assessed in an anonymous survey of nursing staff at baseline and after the launch. The approach resulted in a 40% reduction in nursing time required to complete a glucose reading (from 5.1 min per test at baseline to 3.1 min per test at the post-launch evaluation). The frequency of glucose monitoring increased from a total of 19,438 glucose readings in the baseline evaluation to 35,971 point-of-care sensor scans in the post-launch evaluation. The number of detected hypoglycemic events increased 12-fold, from 88 in the baseline evaluation to 1049 in the post-launch evaluation. Hypoglycemic events continue to impact a large number of LTC residents living with diabetes mellitus. CGM can improve the detection of hypoglycemic events while decreasing nursing workload. A gradual transition to CGM can help overcome underlying barriers and concerns and ensure a sustainable approa","PeriodicalId":52371,"journal":{"name":"JMIR Diabetes","volume":"10 ","pages":"e73485"},"PeriodicalIF":2.6,"publicationDate":"2025-10-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12536920/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145337905","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}